| Announce Date | 12/23/2021 |
| EPS Normalized Actual | $-0.02 (Beat by $0.01) |
| EPS GAAP Actual | $-0.02 (Beat by $0.01) |
| Revenue Actual | $0.03969B |
| Revenue Surprise | Beat by $39.69M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $-2.39095 |
| EPS GAAP Estimate | $-2.39095 |
| Revenue Estimate | $0.192954238B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2022 | -0.24033 | -11.07 | -0.24033 | -0.24033 | 11 |
| Mar 2021 | -1.56209 | -1.7 | -1.56209 | -1.56209 | 10 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | -657 | -658.54141 | 0.03969B | 2.95% | -230.27M |
| FQ1 2025 (Mar 2025) | -657 | -645.18838 | 0.03969B | 2.95% | -363.26M |
| FQ2 2024 (Jun 2024) | -1.5 | -1.5 | 0.0309265B | 100% | 30.93M |
| FQ3 2024 (Sep 2024) | -1.5 | -2.84259 | 0.0309265B | 100% | -219.75M |
| FQ4 2023 (Dec 2023) | -1.5 | -1.5 | 0.038521B | 100% | 38.52M |
| FQ1 2024 (Mar 2024) | -1.5 | -1.5 | 0.038521B | 100% | 38.52M |
| FQ2 2017 (Jun 2017) | -183 | -183 | 0.26463B | 100% | 264.63M |
| FQ3 2017 (Sep 2017) | -232.22 | -232.22 | 0.215753B | 100% | 215.75M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-2.39095
Consensus Revenue Estimates
0.192954238B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.13399 | -- | -0.13399 | -0.13399 | 1 |
| FQ3 2026 (Sep 2026) | -0.13075 | -- | -0.13075 | -0.13075 | 0 |
| FQ2 2026 (Jun 2026) | -0.13075 | -- | -0.13075 | -0.13075 | 0 |
| FQ1 2026 (Mar 2026) | 0.5242 | 125433.84 | 0.5242 | 0.5242 | 0 |
| FQ4 2025 (Dec 2025) | -2.39095 | -27378.62 | -2.39095 | -2.39095 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.18B | -- | 0.18B | 0.18B | 8 |
| FQ3 2026 (Sep 2026) | 0.17B | -- | 0.17B | 0.17B | 8 |
| FQ2 2026 (Jun 2026) | 0.17B | -- | 0.17B | 0.17B | 12 |
| FQ1 2026 (Mar 2026) | 0.35B | 88.5 | 0.35B | 0.35B | 8 |
| FQ4 2025 (Dec 2025) | 0.19B | 79.43 | 0.19B | 0.19B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | 1.54141 | -657 | -658.54141 | 100.23% |
| FQ1 2025 (Mar 2025) | -11.81162 | -657 | -645.18838 | 98.2% |
| FQ2 2024 (Jun 2024) | -1.5 | -1.5 | 100% | |
| FQ3 2024 (Sep 2024) | 1.34259 | -1.5 | -2.84259 | 189.51% |
| FQ4 2023 (Dec 2023) | -1.5 | -1.5 | 100% | |
| FQ1 2024 (Mar 2024) | -1.5 | -1.5 | 100% | |
| FQ2 2017 (Jun 2017) | -183 | -183 | 100% | |
| FQ3 2017 (Sep 2017) | -232.22 | -232.22 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2024 (Dec 2024) | $0.27B | $0.04B | $-230.27M | -580.17% |
| FQ1 2025 (Mar 2025) | $0.4B | $0.04B | $-363.26M | -915.24% |
| FQ2 2024 (Jun 2024) | $0B | $0.03B | $30.93M | 100% |
| FQ3 2024 (Sep 2024) | $0.25B | $0.03B | $-219.75M | -710.55% |
| FQ4 2023 (Dec 2023) | $0B | $0.04B | $38.52M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.04B | $38.52M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $0.26B | $264.63M | 100% |
| FQ3 2017 (Sep 2017) | $0B | $0.22B | $215.75M | 100% |